We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.

We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.
Logo - Business Development Bank of Canada - BDC
Cytochroma Inc. logo
Exited company

Cytochroma Inc.

Details
Region
Ontario
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
Learn more
Lead
Ela Borenstein - Vice president, venture capital at BDC
Ela Borenstein

Vice President

View profile
About the company

Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).